A Double-Masked Clinical Study To Determine The Aqueous Humor Concentration Of Bromfenac Sodium In Subjects Administered Multiple Topical Ocular Doses Of ISV-303 Or Bromday™ Once Daily (QD) Prior To Cataract Surgery.
Phase of Trial: Phase II
Latest Information Update: 07 Jul 2016
At a glance
- Drugs Bromfenac (Primary)
- Indications Ocular inflammation; Ocular pain
- Focus Pharmacokinetics
- Sponsors InSite Vision
- 01 Feb 2012 Actual number of patients changed from 58 to 60.
- 04 Oct 2011 Status changed from planning to completed, according to an InSite Vision media release.
- 07 Jan 2011 New trial record